Martin and Harris Laboratories Limited
- Unlisted share
- Healthcare
- ISIN INE03VV01015
At a glance
Sales
FY24
₹146 Cr
What the company earned from its customers in the year.
Market valuecalculated
₹354 Cr
What the whole company would be worth at GrowFast's indicative price.
Net worth
FY24
₹471 Cr
What the owners would have left on paper if every debt was repaid.
From the company's published figures; sources are beside each figure further down the page.
Key details
- Company
- Martin and Harris Laboratories Limited
- ISIN
- INE03VV01015
- Sector
- Healthcare
- Type of share
- Unlisted equity share
- Indicative price per share
- ₹886.05
- Price last updated
- 12 Oct 2026
- Minimum quantity
- Confirmed by the desk
- How you hold it
- In your own demat account
- Enquiries
- GrowFast desk, on WhatsApp
Indicative prices, illiquid shares. Prices are indicative and can change without notice. Unlisted shares are illiquid: you may not be able to sell when you want to, or at the price shown.
Company
About Martin and Harris Laboratories Limited
Martin and Harris Laboratories is an unlisted public pharmaceutical company, established in 1993, that does research and contract manufacturing of finished dosage forms such as tablets, capsules, dry syrups, liquid orals and ointments. It runs two plants, at Roorkee in Uttarakhand (production from 2008) and at Gagret in Una district, Himachal Pradesh (from 2010), with a corporate office in New Delhi, an R&D centre in Gurugram and its registered office at Pachgaon in Gurgaon district, Haryana. Its annual return for FY2023-24 shows about 87% of the shares held by bodies corporate; Apeejay Stya University's pharmacy school describes Martin & Harris and Walter Bushnell as pharmaceutical companies of the Apeejay Stya group.
Written from: martinharrislabs.com, martinharrislabs.com, martinharrislabs.com, martinharrislabs.com, university.apeejay.edu
Listing status. Not listed: the FY2023-24 annual return states the shares are not listed on any recognised stock exchange Company annual return (Form MGT-7) for FY2023-24, on the company website
Financials
Ask for the full annual report.
The figures on this page are the headline numbers. The desk can share the latest annual report and anything published since.
Ask for the financials- Sector
- Healthcare
- ISIN
- INE03VV01015
- Year of incorporation
- 1993
- Apeejay Stya University, NAAC document 3.7.2 (summary of activities under MoUs)
- Registered office
- Pachgaon, Gurgaon district, Haryana
- Apeejay Stya University, NAAC document 3.7.2 (summary of activities under MoUs)
- Face value per share
- ₹10
- Paid-up equity shares
- 39,96,040 shares
- CIN
- U24239HR1993PLC033630
- Official website
- martinharrislabs.com
Read from: Company annual return (Form MGT-7) for FY2023-24, on the company website, unless another source is shown on a card.
Key data
What the numbers mean
The ratios buyers look at, each said in plain words.
Price to book (P/B)calculated
0.75×
At this price you pay ₹0.75 for every ₹1 of net worth on the company's books.
- Indicative price
- ₹886.05
- Market valuecalculated
- ₹354 Cr
- price × shares
- No. of shares
- 39,96,040
- Book value per share
- ₹1,178.49
- Face value
- ₹10
Figures marked “calculated” are worked out by GrowFast from its indicative price and the company's published figures for FY2023-24. They move with the price, and they are arithmetic, not a valuation.
Figures in ₹ crore
Financials
Martin and Harris Laboratories Limited. As published in the company's audited reports. GrowFast has not audited them.
| Particulars | FY24Latest |
|---|---|
| Turnover (as stated in annual return MGT-7) | 146.15 |
Rupees crore unless marked, standalone (annual return figure). The change shown is the latest year against the year before. Read from: Company annual return (Form MGT-7) for FY2023-24, on the company website.
Ownership
Shareholding pattern
Who owns the company
As of 31 March 2024
86.7%Public: bodies corporate
- Largest holder
- 86.7%
- Top 3 together
- 100.0%
- Holders named
- 4
- Public: bodies corporate86.65%
- Public: Indian individuals / HUF13.34%
- Public: non-resident Indians (100 shares)0.00%
- Promoters (7 holders, 140 shares)0.00%
- Total99.99%
Read from: Company annual return (Form MGT-7) for FY2023-24, on the company website
Leadership
Management
Harnam Singh Thakur
Director (also Nodal Officer for IEPF)
Nasim Uddin
Director
Read from: Company website, Company annual return (Form MGT-7) for FY2023-24, on the company website
Corporate calendar
Events
Reports and filings
Annual reports and results
Each link opens the document where its publisher keeps it.
Before you buy
Six things to check on any unlisted share.
The same list applies to every stock. None of it is advice on this one.
The company's latest financials
Revenue, profit and debt for the last three years, from its audited annual report. Ask the desk for the most recent set.
What the price implies
Compare the price per share with earnings and book value per share, and with listed companies in the same business.
Whether a listing is planned
A company may file for an IPO, delay it or never list. A listing, its timing and its price are never certain.
How you would sell
There is no exchange for these shares. You sell by finding a buyer, which can take time and may be at a lower price.
Lock-in after a listing
Shares bought before an IPO are usually locked in for a period after the company lists. Confirm the current rule before you buy.
Tax on your gains
Unlisted shares are taxed differently from listed ones. Check your position with a tax adviser.
Questions
What buyers ask about this stock.
Not answered here? Ask the desk.
Inquire about Martin and Harris Laboratories Limited on WhatsAppIs the price shown for Martin and Harris Laboratories Limited final?
No. It is an indicative price per share. The desk confirms the price and the quantity available when you inquire, and the confirmed price is the one you deal at.
How do I buy these shares?
Press Inquire. It opens a WhatsApp chat with the desk, with this stock already named. After the price and quantity are agreed, a 10% advance locks the deal. Once your KYC is complete you pay the balance, and the shares are transferred to your demat account.
Do I pay anything on this website?
No. No payment is taken and no order is placed on this site. Payment details are shared by the desk only after the deal is agreed.
What do I need before I can buy?
A demat account in your name and the documents for KYC: your identity and demat account details are verified before any deal, as the regulations require.
Can I sell my Martin and Harris Laboratories Limited shares to GrowFast?
GrowFast buys as well as sells. Press Inquire and tell the desk how many shares you hold; it will come back with what it can offer.
How do I sell Martin and Harris Laboratories Limited shares I already hold?
Tell the desk how many you hold. If a price is agreed, you transfer the shares from your demat account with a delivery instruction to your depository participant (a DIS, or its online equivalent), and payment follows as agreed with the desk.
Is there a lock-in if the company lists?
Shares held before an IPO are generally locked in for a period after the listing under SEBI's rules, which have changed over time. Ask the desk for the rule that applies today before you buy.
Is buying unlisted shares legal in India?
Yes. Shares of an unlisted company can be bought and sold privately and are transferred between demat accounts. They are not traded on a stock exchange, so the protections of an exchange do not apply.
What is the minimum I can buy?
It differs by stock and by what the desk holds at the time. The desk confirms the minimum quantity when you inquire.
What is an ISIN?
The 12-character code that identifies a security. It is how your depository knows exactly which share is being transferred to your demat account.
Why are unlisted shares riskier than listed ones?
Prices are indicative and can change without notice. Unlisted shares are illiquid: you may not be able to sell when you want to, or at the price shown.
Similar stocks
More in Healthcare
- Anglo-French Drugs & Industries Ltd₹1,585.24 · ₹179 Cr · P/E 7.8
- API Holdings Ltd (PharmEasy)₹6.46 · ₹4,539 Cr
- Dantech Digital Dental Solutions Private Limited₹445.50
- Down Town Hospital Limited₹371.25
- Gynofem Healthcare and Pharmaceutical₹63.36
- Hicks Thermometers India Limited₹1,633.50 · ₹45 Cr · P/E 8.1
Risk disclosure
Prices on this site are indicative, quoted per share, and are not an offer to buy or sell. The price and quantity for any deal are confirmed by GrowFast's desk at the time you deal.
Unlisted, pre-IPO and delisted shares are not traded on a stock exchange. They are illiquid, their prices can move sharply, and you may be unable to sell them when you wish or at all. A company that is expected to list may not do so.
Nothing on this site is investment advice or a promise of returns. Past prices do not predict future prices. Consider your own circumstances, and take independent advice, before you invest.
Inquire opens a WhatsApp chat with GrowFast. No payment is taken and no order is placed on this site.
GrowFast is not affiliated with, sponsored by or endorsed by Martin and Harris Laboratories Limited. Its name and logo belong to their owner and are shown only to identify the company. Figures about it come from published sources and have not been audited by GrowFast. See the Terms and Conditions.